Skip to content
10-Q

Quarterly Report

Lazuriton Nano Biotechnology (U.S.A.) Inc.

0001640334-19-001401

← back to feed
Filed
Jul 17, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2019 · Jul 8, 2019 100M sh
Current Liabilities Q1 2019 · Mar 31, 2019 $218.63K
Current Liabilities Q1 2019 · Dec 31, 2018 $198.88K
Total Liabilities Q1 2019 · Mar 31, 2019 $218.63K
Total Liabilities Q1 2019 · Dec 31, 2018 $198.88K
Current Assets Q1 2019 · Mar 31, 2019 $1.26K
Current Assets Q1 2019 · Dec 31, 2018 $2.12K
Total Assets Q1 2019 · Mar 31, 2019 $1.26K
Total Assets Q1 2019 · Dec 31, 2018 $2.12K
Operating Cash Flow Q1 2019 · Mar 31, 2018 $0
Cash And Equivalents Q1 2019 · Mar 31, 2018 $1.19K
Cash And Equivalents Q1 2019 · Dec 31, 2017 $1.19K
Stockholders Equity Q1 2019 · Mar 31, 2018 −$134.19K
Stockholders Equity Q1 2019 · Dec 31, 2017 −$104.24K
Sga Expense Q1 2019 · Mar 31, 2018 $29.95K
Net Income Q1 2019 · Mar 31, 2018 −$29.95K
Operating Income Q1 2019 · Mar 31, 2018 −$29.95K